Quarterly report · Q2
2931.TEDINET S100OYUS
Period2022-01-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks13 of 14 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥21.6bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥34.4bn | 2020-10-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.7bn | 2020-10-01 → 2021-03-31 | Cons. | Net sales |
| Operating income | −¥1.4bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | −¥511m | 2020-10-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | −¥597m | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥6.4bn | 2020-10-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥130m | 2020-10-01 → 2021-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥595m | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥117m | 2020-10-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥465m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥5.0bn | 2020-10-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥196m | 2020-10-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥462m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | −¥194m | 2020-10-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥58.6bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥61.0bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥21.7bn | at 2021-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥38.8bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥40.4bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥19.9bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥20.6bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥11.1bn | at 2021-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.5bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.9bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥9.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.2bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.4bn | 2020-10-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥362m | 2020-10-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥531m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.3bn | 2020-10-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.9bn | 2020-10-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥12.1bn | 2020-10-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.1bn | 2020-10-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-4.18 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.54 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-49.07 | 2020-10-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.1 | 2020-10-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.76 | 2021-01-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 33.1% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.0% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥810m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥63m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥63m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥376m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥20.2bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥20.2bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥122m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥113m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-06-30 | ¥21.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-06-30 | ¥21.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-06-30 | −¥611m |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-03-31 | −¥697m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2020-10-01 → 2021-03-31 | ¥5m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2020-10-01 → 2021-03-31 | ¥5m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2020-10-01 → 2021-03-31 | −¥295m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2020-10-01 → 2021-03-31 | ¥7.4bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2020-10-01 → 2021-03-31 | ¥7.4bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2020-10-01 → 2021-03-31 | ¥624m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2020-10-01 → 2021-03-31 | ¥288m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2020-10-01 → 2021-03-31 | ¥288m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2020-10-01 → 2021-03-31 | −¥143m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-10-01 → 2021-03-31 | ¥7.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-10-01 → 2021-03-31 | ¥7.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-10-01 → 2021-03-31 | ¥185m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 595
| Item | Context | Value | Unit |
|---|---|---|---|
| Non operating expenses | Prior1YTDDuration | 24000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 305000000 | JPY |
| Ordinary income | Prior1YTDDuration | -130000000 | JPY |
| Ordinary income | CurrentYTDDuration | -597000000 | JPY |
| Gain on reversal of subscription rights to shares ei | Prior1YTDDuration | 12000000 | JPY |
| Gain on reversal of subscription rights to shares ei | CurrentYTDDuration | 0 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 0 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 3000000 | JPY |
| Extraordinary income | Prior1YTDDuration | 12000000 | JPY |
| Extraordinary income | CurrentYTDDuration | 3000000 | JPY |
| Loss on sales of noncurrent assets el | Prior1YTDDuration | 0 | JPY |
| Loss on sales of noncurrent assets el | CurrentYTDDuration | 0 | JPY |
| Extraordinary loss | Prior1YTDDuration | 0 | JPY |
| Extraordinary loss | CurrentYTDDuration | 0 | JPY |
| Income before income taxes | Prior1YTDDuration | -117000000 | JPY |
| Income before income taxes | CurrentYTDDuration | -595000000 | JPY |
| Income taxes current | Prior1YTDDuration | 74000000 | JPY |
| Income taxes current | CurrentYTDDuration | 714000000 | JPY |
| Refund of income taxes income taxes | Prior1YTDDuration | － | JPY |
| Refund of income taxes income taxes | CurrentYTDDuration | -102000000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 1000000 | JPY |
| Income taxes deferred | CurrentYTDDuration | -745000000 | JPY |
| Income taxes | Prior1YTDDuration | 76000000 | JPY |
| Income taxes | CurrentYTDDuration | -133000000 | JPY |
| Profit loss | Prior1YTDDuration | -194000000 | JPY |
| Profit loss | CurrentYTDDuration | -462000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 1000000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 3000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | -196000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | -465000000 | JPY |
| Profit loss | Prior1YTDDuration | -194000000 | JPY |
| Profit loss | CurrentYTDDuration | -462000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -0 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 2000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | Prior1YTDDuration | － | JPY |
| Deferred gains or losses on hedges net of tax oci | CurrentYTDDuration | -0 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | -6000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | -25000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | － | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -0 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1YTDDuration | 1000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | CurrentYTDDuration | 4000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | -5000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | -19000000 | JPY |
| Comprehensive income | Prior1YTDDuration | -199000000 | JPY |
| Comprehensive income | CurrentYTDDuration | -481000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | -197000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | -485000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | -1000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 3000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | partial |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |